Development and Characterization of the Patient-Friendly Formulations: Preparation and Characterization of a Suspension Containing Nanoparticulated Rebamipide for Stomatitis

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-C-013-Tuesday
• By: HANAWA, Takehisa (Tokyo University of Science, Faculty of Pharmaceutical Sciences, Noda-City, Japan)
• Co-author(s): Yayoi Kawano: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
  Naoko Ishii: Dept. of Pharmacy, Kashiwa City Hospital, Kashiwa-City, Japan
  Yuichiro Shimizu: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
  Takehisa Hanawa: Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda-City, Japan
  
• Abstract:

  Backgrounds

   Aphthous stomatitis is known to be induced by chemotherapy and radiotherapy. One hundred percent of patients administered high-dose chemotherapy and 80% of patients receiving radiotherapy develop stomatitis. Furthermore, it has been reported that stomatitis is a prominent clinical problem affecting approximately 40% of patients..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login